Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: J Clin Psychiatry. 2010 May 18;71(12):1680–1688. doi: 10.4088/JCP.09m05089gry

Table 1.

Participant Demographic and Baseline Characteristics

OROS-MPH (N=127) Placebo (N=128)
Age (Years) 38.1 (10.4) 37.5 (9.6)
Sex (% Male) 60.6 52.3
Race/Ethnicity (%)
 African-American 4.8 7.0
 Caucasian 86.4 78.9
 Asian 1.6 1.6
 Native American/Alaskan 0.8 0
 Other 3.2 4.7
 Mixed race 3.2 7.8
 Hispanic 7.9 6.3
Marital Status (%)
 Married 40.5 27.8
 Separated/Divorced/Widowed 17.4 25.4
 Never Married 42.1 46.8
Education (Years) 14.4 (2.4) 14.5 (2.4)
Employed Full/Part time (%) 94.4 89.7
Lifetime Psychiatric Comorbidity (%)
 Major depression 32.3 35.9
 Bipolar disorder 0.0 0.0
 Anxiety disorder 34.6 32.8
 Substance use disorder 63.0 58.6
DSM-IV ADHD Rating Scale Total Score 36.0 (7.1) 36.7 (7.5)
Adult ADHD subtype (%)
 Inattentive 25.2 23.4
 Hyperactive-Impulsive 2.4 0.8
 Combined 72.4 75.8
Smoking history
 Fagerström score 5.6 (2.1) 5.4 (2.3)
 No. of Smoking years 19.9 (10.0) 19.5 (9.3)
 No. of cigarettes/day 19.8 (8.1) 19.8 (7.5)
 No. of past quit attempts 7.5 (10.3) 6.4 (9.8)

Note. Where not specifically indicated, numbers represent means (standard deviations).